Cell Counting Market Size – By Product Type (Instruments [Hemocytometers, Automated Cell Counters, Hematology Analyzers], Consumable & Reagents), Application (Complete Blood Count, Cell-based Therapies, Toxicity), End-user & Forecast, 2024 ­ 2032

Cell Counting Market Size

Cell Counting Market size was valued at USD 11.7 billion in 2023 and is expected to grow at a CAGR of 6.6% between 2024 and 2032, owing to the rising incidence of chronic diseases such as HIV, measles, diphtheria, cancer, and blood disorders, prompting an intense need for precise cell counting in diagnosis, treatment monitoring, and research activities.
 

For instance, according to UNAIDS data revealed that around 39 million individuals worldwide were living with HIV in 2022, with approximately 1.3 million new infections. Comparatively, in 2021, an estimated 1.5 million new HIV infections occurred. These escalating incidence rates underscore the imperative for accurate cell counting and diagnostic tests, thereby driving market growth.
 

Cell counting refers to the process of quantifying the number of cells within a sample. In the context of the cell counting market, it involves the use of various techniques and instruments to accurately determine the concentration of cells in a given solution or suspension. These techniques can include manual counting using a hemocytometer, automated counting using cell counters, flow cytometry, or image-based analysis systems.
 

Cell Counting Market Trends

• The increased focus on exploring regenerative medicine, immunotherapy, and cell-based therapies for diverse diseases has reinforced the demand for precise cell-counting tools, thereby augmenting the market growth.
   
• Also, rising research funding for cell-based therapeutics further fuels expansion in the cell counting industry. For instance, in March 2023, the Stem Cell Research and Eli and Edythe Broad Center of Regenerative Medicine at UCLA secured over USD 5.7 million in funding from the California Institute for Regenerative Medicine. This funding aimed to bolster stem cell-based technologies for treating cancer and intellectual disabilities. Thus, accurate cell counting is crucial for assessing cell viability, proliferation, and dosage, playing a pivotal role in advancing R&D in this domain and consequently facilitating market expansion.
   

Cell Counting Market Analysis

Based on the product type, the market is categorized into instruments and consumables & reagents The instruments are further classified as hemocytometers, automated cell counters, hematology analyzers, image cytometry, and other instruments. The consumables and reagents segment is poised to expand at a CAGR of 6.7% through 2032.
 

• Consumables and reagents have emerged as dominant segments in the cell counting market, reflecting their crucial role in facilitating accurate and efficient cell counting processes. Their dominance is attributed to the recurring demand for these consumables across various research, clinical, and bioprocessing applications.
   
• Additionally, the introduction of innovative products drives segment expansion. For instance, in December 2020, eNuvio introduced a reusable 3D cell culture microplate, anticipating long-term benefits for scientists in terms of both economics and scientific advancements. This environmentally friendly device is poised to offer sustainable solutions while catering to the evolving needs of researchers in the field.
   
• Thus, advancements in cell counting technologies have spurred the development of innovative consumables and reagents, further bolstering their prominence in driving market growth.

Based on application, the cell counting market is classified into complete blood count, cell-based therapies, bioprocessing, toxicity, and other applications. The complete blood count segment recorded around 47.5% of the market share in 2023.
 

• The complete blood count stands as a pivotal test for assessing an individual's overall health, measuring various blood components including RBC, WBC, hemoglobin, hematocrit, and platelets.
   
• The rising prevalence of blood disorders such as anemia and leukemia is expected to propel segment growth, given the complete blood count widespread use in monitoring such conditions. For instance, in July 2022, MicroBioSensor introduced QUICKCHECK, a collaborative effort with Smallfry, offering a rapid and portable leukocyte count test device. This innovation enables nurses to conduct instant tests conveniently at patients' homes, enhancing accessibility and efficiency in healthcare delivery.
   

Based on the end-user, the cell counting market is classified into hospitals, diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies, and other end-users. Hospital segment is set to cross USD 5.8 billion by end of 2032.
 

• The segment prominence stems from the pivotal role hospitals play as primary healthcare providers, necessitating extensive use of cell counting technologies for various diagnostic and monitoring purposes.
   
• Additionally, hospitals often comprises well-equipped laboratories and specialized departments where cell counting instruments are routinely utilized. Also, the high volume of patients, coupled with the diverse range of medical conditions treated in hospitals, drives consistent demand for cell counting devices and consumables, thereby consolidating hospital position as key contributors to the market growth.

North America cell counting market accounted for 38% of the revenue share in 2023.
 

• The substantial market share is primarily attributed to several factors, including a larger patient population, increased adoption of high-throughput flow cytometry and automated hematology analyzers in healthcare settings, and the presence of key industry players in the region.  Moreover, the introduction of new products in the region, such as BD's benchtop cell analyzer introduced in August 2021 has further supplemented the market expansion.
   

Cell Counting Market Share

The cell counting industry exhibits significant competitiveness with key players emphasizing innovation, strategic collaborations, and product launches to sustain their market standing. Additionally, partnerships with research institutions and healthcare facilities, coupled with geographic expansions, serve as common strategies to bolster market presence and secure significant revenue share.
 

Cell Counting Market Companies

Prominent players operating in the cell counting industry are as mentioned below:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Biotek Instruments, Inc.
• ChemoMetec A/S
• DeNovix
• Merck KGaA
• NanoEnTek Inc
• Olympus Corporation
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
   

Cell Counting Industry News

• In May 2023, Sysmex Corporation launched its clinical flow cytometry system flow cytometer XF-1600, sample preparation system PS-10, antibody reagents, and associated products in Japan. This launch aimed to enhance testing efficiency and standardization, relieving clinical technologists of routine tasks to focus on more intricate analysis, thereby strengthening its market presence.
   
• In February 2022, Abacus dx entered into a partnership with Luminex concerning the Guava series of flow cytometry instruments and reagents. Under this agreement, Abacus dx will commercialize Luminex's Guava line of flow cytometry instruments and reagents. The partnership aimed to accelerate the sales of Guava range products, bolstering their market presence and sales channels.
   

The cell counting market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Instruments
  • Hemocytometers
  • Automated cell counters
    • Fluorescence image-based cell counter
    • Flow cytometer
    • Coulter counter
  • Hematology analyzers
    • Fully automated analyzers
    • Semi-automated analyzers
  • Image cytometry
  • Other instruments
• Consumables & reagents

Market, By Application

• Complete blood count
• Cell-based therapies
• Bioprocessing
• Toxicity
• Other applications

Market, By End-user

• Hospitals
• Diagnostic laboratories
• Research institutes
• Pharmaceutical & biotechnology companies
• Other end-users

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa